Generic Levothyroxine - Addendum
Superseded by The Medical Letter "Influenza Vaccine for 2011-2012" - Issue 1375, October 17, 2011
In preparing the Canadian edition of the September 27 issue, we noticed that the Canadian price for Synthroid is $6.40 (US $4.92) for 100 100-mcg tablets, compared to $52.70 in the US, an extraordinary 10-fold difference. Synthroid may have been reformulated in the US after the FDA in 1997 required all manufacturers of levothyroxine to file new drug applications because of concerns about the potency of various formulations, including Synthroid. The FDA approved Synthroid in 2002. Health Canada found no indication of a quality concern with Synthroid tablets in 2002, but in July 2004 it announced that levothyroxine will be regulated as a new drug there as well, and additional evidence of safety, efficacy and quality may be required....
In preparing the Canadian edition of the September 27 issue, we noticed that the Canadian price for Synthroid is $6.40 (US $4.92) for 100 100-mcg tablets, compared to $52.70 in the US, an extraordinary 10-fold difference. Synthroid may have been reformulated in the US after the FDA in 1997 required all manufacturers of levothyroxine to file new drug applications because of concerns about the potency of various formulations, including Synthroid. The FDA approved Synthroid in 2002. Health Canada found no indication of a quality concern with Synthroid tablets in 2002, but in July 2004 it announced that levothyroxine will be regulated as a new drug there as well, and additional evidence of safety, efficacy and quality may be required....
Cannot Access - We are sorry, but you cannot access the requested article.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
Information about the article:
Title: Generic Levothyroxine - Addendum
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1193
Article Code: 1193c
Date: October 11, 2004
Volume: 46
Page: 81
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1193
Article Code: 1193c
Date: October 11, 2004
Volume: 46
Page: 81
Subscribe to The Medical Letter on Drugs and Therapeutics for instant access to this article. Add this downloadable, electronic article to your cart (U.S. English version only)